@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix schem: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 occursIn: obo:UBERON_0004237, species:10116; rdf:object schem:Cyclic%20GMP; rdf:predicate belv:increases; rdf:subject chebi:7583; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:\"nitric oxide\") -> a(SCHEM:\"Cyclic GMP\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_3; pav:version "20131211" . sub:_2 prov:value "Endothelialderived relaxing factors, such as NO or prostacyclin (PGI2), relax blood vessels and inhibit the proliferation and migration of SMCs by increasing the synthesis of the cyclic nucleotides cAMP or cGMP."; prov:wasQuotedFrom pubmed:14692693 . sub:_3 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:14692693; prov:wasDerivedFrom beldoc:, sub:_2 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:13.616+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }